Abstract
As disease etiologies are becoming more complex and comorbidity more common, the prospect of combining two therapeutic agents in a single topical preparation is increasingly attractive. In spite of this welcoming clinical context, eutectic systems, which are specifically designed to generate highly effective medicines using drug combinations, have not achieved the commercial success that was once predicted. One reason for this is that the manner in which they act to promote transport across biological barriers remains unclear, and this slows down the development process for these products. This chapter reviews the current understanding of eutectic systems for penetration enhancement and uses the oft-cited example of lidocaine and prilocaine, commercialized as EMLA cream®, to try and gain a better understanding of how eutectic systems work in promoting drug delivery into and across the skin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander A, Dwivedi SA, Giri TK, Saraf S, Tripathi DK (2012) Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 164:26–40
Benson HA (2005) Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2:23–33
Brodin A, Nyqvist-Mayer A, Wadsten T, Forslund B, Broberg F (1984) Phase diagram and aqueous solubility of the lidocaine-prilocaine binary system. J Pharm Sci 73:481–484
Davis AF, Hadgraft J (1991) Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int J Pharm 76:1–8
Dias M, Hadgraft J, Lane ME (2007) Influence of membrane-solvent-solute interactions on solute permeation in model membranes. Int J Pharm 336:108–114
Fedors RF (1974) Method for estimating both the solubility parameters and molar volumes of liquids. Polym Eng Sci 14:147–154
Fiala S, Brown MB, Jones SA (2008) An investigation into the influence of binary drug solutions upon diffusion and partition processes in model membranes. J Pharm Pharmacol 60:1615–1623
Fiala S, Brown MB, Jones SA (2010) A fundamental investigation into the effects of eutectic formation on transmembrane transport. Int J Pharm 393:68–73
Fiala S, Brown MB, Jones SA (2011) Dynamic in-situ eutectic formulations. J Pharm Pharmacol 63:1428–1436
Henry R. (1999). Prilocaine and hydrofluorocarbon aerosol preparations. US patent no. 5858331, 12 Jan 1999
Henry R, Morales A (2003) Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res 15:277–281
Henry R, Morales A, Wyllie MG (2008) TEMPE: topical eutectic-like mixture for premature ejaculation. Expert Opin Drug Deliv 5:251–261
Higuchi WI (1962) Analysis of data on the medicament release from ointments. J Pharm Sci 51:802–804
Iervolino M, Cappello B, Raghavan SL, Hadgraft J (2001) Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm 212:131–141
Isama K, Kojima S, Nakamura A (1993) Phase studies of a urethane model compound and polyether macroglycols by infrared spectroscopy and the relationship between eutectic composition of soft segment and blood compatibility. J Biomed Mater Res 27:539–545
Juhlin L, Evers H, Broberg F (1980) A lidocaine-prilocaine cream for superficial skin surgery and painful lesions. Acta Derm Venereol 60:544–546
Kang L, Jun HW, McCall JW (2000) Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport. Int J Pharm 206:35–42
Kaplun-Frischoff Y, Touitou E (1997) Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci 86:1394–1399
Kasting GB, Smith RL, Cooper ER (1987) Effects of lipid solubility and molecular size on percutaneous absorption. Pharmacol Skin 1:138–153
Nyqvist-Mayer AA, Brodin AF, Frank SG (1986) Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase. J Pharm Sci 75:365–373
Potts RO, Guy RH (1992) Predicting skin permeability. Pharm Res 9:663–669
Pugh WJ, Roberts MS, Hadgraft J (1996) Epidermal permeability – penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int J Pharm 138:149–165
Reid ML, Brown MB, Moss GP, Jones SA (2008) An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes. J Pharm Pharmacol 60:1139–1147
Scheuplein RJ, Blank IH (1971) Permeability of the skin. Physiol Rev 51:702–747
Stott PW, Williams AC, Barry BW (1998) Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Control Release 50:297–308
Stott PW, Williams AC, Barry BW (2001) Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. Int J Pharm 219:161–176
Suhonen TM, Bouwstra JA, Urtti A (1999) Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release 59:149–161
Touitou E, Chow DD, Lawter JR (1994) Chiral β-blockers for transdermal delivery. Int J Pharm 104:19–28
Twist JN, Zatz JL (1986) Influence of solvents on paraben permeation through idealized skin model membranes. J Soc Cosmet Chem 37:291
Watanabe H, Obata Y, Ishida K et al (2009) Effect of l-menthol on the thermotropic behavior of ceramide 2/cholesterol mixtures as a model for the intercellular lipids in stratum corneum. Colloids Surf B 73:116–121
Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603–618
Wood DG, Brown MB, Jones SA (2012) Understanding heat facilitated drug transport across human epidermis. Eur J Pharm Biopharm 81:642–649
Woolfson AD, Malcolm RK, Campbell K, Jones DS, Russell JA (2000) Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J Contr Release 67:395–408
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jones, S.A., Fiala, S., Brown, M.B. (2015). Eutectic Systems for Penetration Enhancement. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45013-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-45013-0_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45012-3
Online ISBN: 978-3-662-45013-0
eBook Packages: MedicineMedicine (R0)